NZ266052A - Tricyclodecyl ester of 1s-[2-[(2-hydroxycyclohexyl)amino]-1-(1h-indol-3-ylmethyl)-1- methyl-2-oxo ethyl]-carbamate - Google Patents

Tricyclodecyl ester of 1s-[2-[(2-hydroxycyclohexyl)amino]-1-(1h-indol-3-ylmethyl)-1- methyl-2-oxo ethyl]-carbamate

Info

Publication number
NZ266052A
NZ266052A NZ266052A NZ26605294A NZ266052A NZ 266052 A NZ266052 A NZ 266052A NZ 266052 A NZ266052 A NZ 266052A NZ 26605294 A NZ26605294 A NZ 26605294A NZ 266052 A NZ266052 A NZ 266052A
Authority
NZ
New Zealand
Prior art keywords
hydroxycyclohexyl
indol
ylmethyl
carbamate
amino
Prior art date
Application number
NZ266052A
Inventor
David Christopher Horwell
Janak Khimchand Padia
Martyn Clive Pritchard
Bharat Kalidas Trivedi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to NZ266052A priority Critical patent/NZ266052A/en
Publication of NZ266052A publication Critical patent/NZ266052A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NZ266052A 1994-03-10 1994-03-10 Tricyclodecyl ester of 1s-[2-[(2-hydroxycyclohexyl)amino]-1-(1h-indol-3-ylmethyl)-1- methyl-2-oxo ethyl]-carbamate NZ266052A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ266052A NZ266052A (en) 1994-03-10 1994-03-10 Tricyclodecyl ester of 1s-[2-[(2-hydroxycyclohexyl)amino]-1-(1h-indol-3-ylmethyl)-1- methyl-2-oxo ethyl]-carbamate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1994/002573 WO1995024389A1 (en) 1994-03-10 1994-03-10 Indole derivatives as cck receptor antagonists
NZ266052A NZ266052A (en) 1994-03-10 1994-03-10 Tricyclodecyl ester of 1s-[2-[(2-hydroxycyclohexyl)amino]-1-(1h-indol-3-ylmethyl)-1- methyl-2-oxo ethyl]-carbamate

Publications (1)

Publication Number Publication Date
NZ266052A true NZ266052A (en) 1999-07-29

Family

ID=22242333

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ266052A NZ266052A (en) 1994-03-10 1994-03-10 Tricyclodecyl ester of 1s-[2-[(2-hydroxycyclohexyl)amino]-1-(1h-indol-3-ylmethyl)-1- methyl-2-oxo ethyl]-carbamate

Country Status (8)

Country Link
EP (1) EP0749422A1 (en)
JP (1) JP3361100B2 (en)
KR (1) KR100311329B1 (en)
AU (1) AU677844B2 (en)
FI (1) FI109689B (en)
NO (1) NO307176B1 (en)
NZ (1) NZ266052A (en)
WO (1) WO1995024389A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010089A (en) * 1988-08-12 1991-04-23 Biomeasure, Inc. CCK antagonists and their use in treating gastrointestinal disorders
US5244915A (en) * 1990-08-31 1993-09-14 Warner-Lambert Company Amico acid derivatives cyclized at the c-terminal
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives

Also Published As

Publication number Publication date
WO1995024389A1 (en) 1995-09-14
KR970701694A (en) 1997-04-12
FI963463A0 (en) 1996-09-04
AU6663394A (en) 1995-09-25
JP3361100B2 (en) 2003-01-07
FI109689B (en) 2002-09-30
JPH09510440A (en) 1997-10-21
KR100311329B1 (en) 2002-02-28
AU677844B2 (en) 1997-05-08
FI963463A (en) 1996-09-04
NO307176B1 (en) 2000-02-21
NO963775D0 (en) 1996-09-09
NO963775L (en) 1996-09-09
EP0749422A1 (en) 1996-12-27

Similar Documents

Publication Publication Date Title
GB2326339B (en) Enteric-coated pharmaceutical compositions of mycophenolate
DE69607328D1 (en) EPOXY CYANATE ESTER COMPOSITIONS
HUP9901718A3 (en) Analogs of parathyroid hormone
GB9506493D0 (en) The implementation of trick-play modes for pre-encoded video
GB9512290D0 (en) Uses of polyhexanide
EP1021407A4 (en) Synthesis of clasto-lactacystin beta-lactone and analogs thereof
IT1276799B1 (en) FORMULATIONS OF F-SILICONE
NZ266052A (en) Tricyclodecyl ester of 1s-[2-[(2-hydroxycyclohexyl)amino]-1-(1h-indol-3-ylmethyl)-1- methyl-2-oxo ethyl]-carbamate
AU5483596A (en) Neuropeptide y analogs
GR3035866T3 (en) Para-hydroxyphenylacetic acid for veducing the repellency of insecticides
GB9614889D0 (en) Ceramide promoters of haematopoiesis
GB9503997D0 (en) Image motion compensation
ITBO950071A0 (en) PROCEDURE FOR TRANSFERRING AN IMAGE TO A SUPPORT
KR100238085B1 (en) Video split board of mcu
KR0130850Y1 (en) Shaft structure of focus-pack of fbt
FR2763310B1 (en) IMPROVEMENT OF A VERTICAL TAKE OFF AIRCRAFT
SI0892640T1 (en) Enteric-coated pharmaceutical compositions of mycophenolate
KR970048085U (en) Balance of television
KR970003631U (en) Flyback Trans Shield Support Structure of Monitor
KR970015538U (en) Facsimile's operating assembly switchgear
LV12147A (en) Synthesis of 2-oxo-4-phenylbutanediyl ethyl ester from 2,2-diethoxy-4-phenylbutenoic acid ethyl ester \ t
PL306636A1 (en) Method of obtaining novel ethyl (e)-3-methyl-6-trimethylsilicium 4-hexenic ester
LV11891A (en) Ethyl ester yield of 2-oxo-4-phenylbutanediyl
KR970014973U (en) Head drum video head assembly structure
TW335856U (en) Structure of an air-tight (addition 1)